Dexmedetomidine: Pediatric pharmacology, clinical uses and safety

Expert Opinion on Drug Safety

Volumn 10, Issue 1, 2011, Pages 55-66

  Su, Felice ^a   Hammer, Gregory B ^b  

^a STANFORD UNIVERSITY   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

2 agonist; adverse effects; dexmedetomidine; indications; pediatrics; sedation

Indexed keywords

DEXMEDETOMIDINE; INTERLEUKIN 1; INTERLEUKIN 6; PLACEBO; TUMOR NECROSIS FACTOR ALPHA;

BRADYCARDIA; BREATHING RATE; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; DELIRIUM; DRUG CLEARANCE; DRUG EFFECT; DRUG FEVER; DRUG HYDROXYLATION; DRUG MECHANISM; DRUG MEGADOSE; DRUG OVERDOSE; DRUG SAFETY; DRUG TOLERANCE; DRUG USE; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAM; FOOD AND DRUG ADMINISTRATION; GENERAL ANESTHESIA; HEART OUTPUT; HUMAN; HYPERTENSION; HYPOTENSION; INTENSIVE CARE UNIT; LOADING DRUG DOSE; MEAN ARTERIAL PRESSURE; NUCLEAR MAGNETIC RESONANCE IMAGING; PEDIATRICS; PREMATURITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEDATION; SEIZURE; SINGLE DRUG DOSE; SYSTOLIC BLOOD PRESSURE;

ADRENERGIC ALPHA-2 RECEPTOR AGONISTS; CARDIOVASCULAR DISEASES; CHILD; DEXMEDETOMIDINE; DRUG TOXICITY; HUMANS; HYPNOTICS AND SEDATIVES;

EID: 78650456887     PISSN: 14740338     EISSN: None     Source Type: Journal    
DOI: 10.1517/14740338.2010.512609     Document Type: Review

References (83)

1. Gerlach AT, Dasta JF. Dexmedetomidine: an updated review. Ann Pharmacother 2007;41:245-54
2. Tobias JD. Dexmedetomidine: applications in pediatric critical care and pediatric anesthesiology. Pediatr Crit Care Med 2007;8:115-31 (Pubitemid 46568561)
3. Virtanen R, Savola JM, Saano V, Nyman L. Characterization of the selectivity, specificity and potency of medetomidine as an alpha 2-adrenoceptor agonist. Eur J Pharmacol 1988;150:9-14
4. Williams JT, Henderson G, North RA. Characterization of alpha 2-adrenoceptors which increase potassium conductance in rat locus coeruleus neurones. Neuroscience 1985;14:95-101 (Pubitemid 15124286)
5. Schwartz DD. Activation of alpha-2 adrenergic receptors inhibits norepinephrine release by a pertussis toxin-insensitive pathway independent of changes in cytosolic calcium in cultured rat sympathetic neurons. J Pharmacol Exp Ther 1997;282:248-55
6. Correa-Sales C, Rabin BC, Maze M. A hypnotic response to dexmedetomidine, an alpha 2 agonist, is mediated in the locus coeruleus in rats. Anesthesiology 1992;76:948-52
7. Correa-Sales C, Reid K, Maze M. Pertussis toxin-mediated ribosylation of G proteins blocks the hypnotic response to an alpha 2-agonist in the locus coeruleus of the rat. Pharmacol Biochem Behav 1992;43:723-7
8. Doze VA, Chen BX, Maze M. Dexmedetomidine produces a hypnotic-anesthetic action in rats via activation of central alpha-2 adrenoceptors. Anesthesiology 1989;71:75-9 (Pubitemid 19182469)
9. Nacif-Coelho C, Correa-Sales C, Chang LL, Maze M. Perturbation of ion channel conductance alters the hypnotic response to the alpha 2-adrenergic agonist dexmedetomidine in the locus coeruleus of the rat. Anesthesiology 1994;81:1527-34 (Pubitemid 24381446)
10. Nelson LE, Lu J, Guo T, et al. The alpha2-adrenoceptor agonist dexmedetomidine converges on an endogenous sleep-promoting pathway to exert its sedative effects. Anesthesiology 2003;98:428-36 (Pubitemid 36592812)
11. Huupponen E, Maksimow A, Lapinlampi P, et al. Electroencephalogram spindle activity during dexmedetomidine sedation and physiological sleep. Acta Anaesthesiol Scand 2008;52:289-94
12. Mason KP, OMahony E, Zurakowski D, et al. Effects of dexmedetomidine sedation on the EEG in children. Pediatr Anesth 2009;19:1175-83
13. Hunter JC, Fontana DJ, Hedley LR, et al. Assessment of the role of alpha2-adrenoceptor subtypes in the antinociceptive, sedative and hypothermic action of dexmedetomidine in transgenic mice. Br J Pharmacol 1997;122:1339-44
14. Lakhlani PP, MacMillan LB, Guo TZ, et al. Substitution of a mutant alpha2a-adrenergic receptor via "hit and run" gene targeting reveals the role of this subtype in sedative, analgesic, and anesthetic-sparing responses in vivo. Proc Natl Acad Sci USA 1997;94:9950-5 (Pubitemid 27408171)
15. Stone LS, MacMillan LB, Kitto KF, et al. The alpha2a adrenergic receptor subtype mediates spinal analgesia evoked by alpha2 agonists and is necessary for spinal adrenergic-opioid synergy. J Neurosci 1997;17:7157-65
16. Yaksh TL. Pharmacology of spinal adrenergic systems which modulate spinal nociceptive processing. Pharmacol Biochem Behav 1985;22:845-58
17. Altman JD, Trendelenburg AU, MacMillan L, et al. Abnormal regulation of the sympathetic nervous system in alpha2A-adrenergic receptor knockout mice. Mol Pharmacol 1999;56:154-61 (Pubitemid 29309824)
18. Link RE, Desai K, Hein L, et al. Cardiovascular regulation in mice lacking alpha2-adrenergic receptor subtypes b and c. Science 1996;273:803-5 (Pubitemid 26271527)
19. MacMillan LB, Hein L, Smith MS, et al. Central hypotensive effects of the alpha2a-adrenergic receptor subtype. Science 1996;273:801-3 (Pubitemid 26271526)
20. Su F, Nicolson SC, Gastonguay MR, et al. Population pharmacokinetics of dexmedetomidine in infants after open heart surgery. Anesth Analg 2010;110:1383-92
21. Bejian S, Valasek C, Nigro JJ, et al. Prolonged use of dexmedetomidine in the paediatric cardiothoracic intensive care unit. Cardiol Young 2009;19:98-104
22. Tasdogan M, Memis D, Sut N, Yuksel M. Results of a pilot study on the effects of propofol and dexmedetomidine on inflammatory responses and intraabdominal pressure in severe sepsis. J Clin Anesth 2009;21:394-400
23. Venn RM, Bryant A, Hall GM, Grounds RM. Effects of dexmedetomidine on adrenocortical function, and the cardiovascular, endocrine and inflammatory responses in post-operative patients needing sedation in the intensive care unit. Br J Anaesth 2001;86:650-6 (Pubitemid 32409406)
24. Hunter JC, Fontana DJ, Hedley LR, et al. Assessment of the role of alpha2-adrenoceptor subtypes in the antinociceptive, sedative and hypothermic action of dexmedetomidine in transgenic mice. Br J Pharmacol 1997;122:1339-44
25. Kable JW, Murrin LC, Bylund DB. In vivo gene modification elucidates subtype-specific functions of alpha2-adrenergic receptors. J Pharmacol Exp Ther 2000;293:1-7
26. Karol MD. Pharmacokinetics and interaction pharmacodynamics of dexmedetomidine in humans. Best Pract Res Clin Anaesthesiol 2000;14:261-9
27. Cunningham FE, Baughman VL, Tonkovich L, et al. Pharmacokinetics of dexmedetomidine in patients with hepatic failure [abstract]. Clin Pharmacol Ther 1999;65:128
28. De Wolf AM, Fragen RJ, Avram MJ, et al. The pharmacokinetics of dexmedetomidine in volunteers with severe renal impairment. Anesth Analg 2001;93:1205-9 (Pubitemid 33021018)
29. Petroz GC, Sikich N, James M, et al. A phase I, two-center study of the pharmacokinetics and pharmacodynamics of dexmedetomidine in children. Anesthesiology 2006;105:1098-110 (Pubitemid 44808573)
30. Diaz SM, Rodarte A, Foley J, Capparelli EV. Pharmacokinetics of dexmedetomidine in postsurgical pediatric intensive care unit patients: preliminary study. Pediatr Crit Care Med 2007;8:419-24 (Pubitemid 47415293)
31. Potts AL, Warman GR, Anderson BJ. Dexmedetomidine disposition in children: a population analysis. Pediatr Anesth 2008;18:722-30
32. Vilo S, Rautiainen P, Kaisti K, et al. Pharmacokinetics of intravenous dexmedetomidine in children under 11 yr of age. Br J Anaesth 2008;100:697-700 (Pubitemid 351774374)
33. Potts AL, Anderson BJ, Warman GR, et al. Dexmedetomidine pharmacokinetics in pediatric intensive care - a pooled analysis. Pediatr Anesth 2009;19:1119-29
34. Tobias JD, Berkenbosch JW. Sedation during mechanical ventilation in infants and children: dexmedetomidine versus midazolam. South Med J 2004;97:451-5
35. Hosokawa K, Shime N, Kato Y, et al. Dexmedetomidine sedation in children after cardiac surgery. Pediatr Crit Care Med 2010;11:39-43
36. Czaja AS, Zimmerman JJ. The use of dexmedetomidine in critically ill children. Pediatr Crit Care Med 2009;10:381-6
37. Carroll CL, Krieger D, Campbell M, et al. Use of dexmedetomidine for sedation of children hospitalized in the intensive care unit. J Hosp Med 2008;3:142-7 (Pubitemid 351722126)
38. Chrysostomou C, Di Filippo S, Manrique AM, et al. Use of dexmedetomidine in children after cardiac and thoracic surgery. Pediatr Crit Care Med 2006;7:126-31
39. Chrysostomou C, De Toledo JS, Avolio T, et al. Dexmedetomidine use in a pediatric cardiac intensive care unit: can we use it in infants after cardiac surgery? Pediatr Crit Care Med 2009;10:654-60
40. Reiter PD, Pietras M, Dobyns EL. Prolonged dexmedetomidine infusions in critically ill infants and children. Indian Pediatr 2009;46:767-73
41. Walker J, Maccallum M, Fischer C, et al. Sedation using dexmedetomidine in pediatric burn patients. J Burn Care Res 2006;27:206-10 (Pubitemid 43970324)
42. Koroglu A, Demirbilek S, Teksan H, et al. Sedative haemodynamic and respiratory effects of dexmedetomidine in children undergoing magnetic resonance imaging examination: preliminary results. Br J Anaesth 2005;94:821-4 (Pubitemid 40754000)
43. Koroglu A, Teksan H, Sagir O, et al. A comparison of the sedative hemodynamic and respiratory effects of dexmedetomidine and propofol in children undergoing magnetic resonance imaging. Anesth Analg 2006;103:63-7 (Pubitemid 44036032)
44. Heard C, Burrows F, Johnson K, et al. A comparison of dexmedetomidine-midazolam with propofol for maintenance of anesthesia in children undergoing magnetic resonance imaging. Anesth Analg 2008;107:1832-9
45. Berkenbosch JW, Wankum PC, Tobias JD. Prospective evaluation of dexmedetomidine for noninvasive procedural sedation in children. Pediatr Crit Care Med 2005;6:435-9
46. Lubisch N, Roskos R, Berkenbosch JW. Dexmedetomidine for procedural sedation in children with autism and other behavior disorders. Pediatr Neurol 2009;41:88-94
47. Mahmoud M, Gunter J, Donnelly LF, et al. A comparison of dexmedetomidine with propofol for magnetic resonance imaging sleep studies in children. Anesth Analg 2009;109:745-53
48. Mason KP, Zgleszewski SE, Dearden JL, et al. Dexmedetomidine for pediatric sedation for computed tomography imaging studies. Anesth Analg 2006;103:57-62 (Pubitemid 44036031)
49. Mason KP, Zgleszewski SE, Prescilla R, et al. Hemodynamic effects of dexmedetomidine sedation for CT imaging studies. Pediatr Anesth 2008;18:393-402 (Pubitemid 351490477)
50. Mason KP, Zurakowski D, Zgleszewski SE, et al. High dose dexmedetomidine as the sole sedative for pediatric MRI. Pediatr Anesth 2008;18:403-11 (Pubitemid 351490487)
51. Ray T, Tobias JD. Dexmedetomidine for sedation during electroencephalographic analysis in children with autism pervasive developmental disorders and seizure disorders. J Clin Anesth 2008;20:364-8
52. Tosun Z, Akin A, Guler G, et al. Dexmedetomidine-ketamine and propofol-ketamine combinations for anesthesia in spontaneously breathing pediatric patients undergoing cardiac catheterization. J Cardiothorac Vasc Anesth 2006;20:515-19 (Pubitemid 44119260)
53. Munro HM, Tirotta CF, Felix DE, et al. Initial experience with dexmedetomidine for diagnostic and interventional cardiac catheterization in children. Pediatr Anesth 2007;17:109-12
54. Hammer GB, Sam WJ, Chen MI, et al. Determination of the pharmacodynamic interaction of propofol and dexmedetomidine during esophagogastroduodenoscopy in children. Pediatr Anesth 2009;19:138-44
55. Erdil F, Demirbilek S, Begec Z, et al. The effects of dexmedetomidine and fentanyl on emergence characteristics after adenoidectomy in children. Anaesth Intensive Care 2009;37:571-6
56. Guler G, Akin A, Tosun Z, et al. Single-dose dexmedetomidine reduces agitation and provides smooth extubation after pediatric adenotonsillectomy. Pediatr Anesth 2005;15:762-6 (Pubitemid 43960893)
57. Ibacache ME, Munoz HR, Brandes V, Morales AL. Single-dose dexmedetomidine reduces agitation after sevoflurane anesthesia in children. Anesth Analg 2004;98:60-3 (Pubitemid 38029843)
58. Isik B, Arslan M, Tunga AD, Kurtipek O. Dexmedetomidine decreases emergence agitation in pediatric patients after sevoflurane anesthesia without surgery. Pediatr Anesth 2006;16:748-53 (Pubitemid 44365964)
59. Shukry M, Clyde MC, Kalarickal PL, Ramadhyani U. Does dexmedetomidine prevent emergence delirium in children after sevoflurane-based general anesthesia? Pediatr Anesth 2005;15:1098-104
60. Tobias JD, Goble TJ, Bates G, et al. Effects of dexmedetomidine on intraoperative motor and somatosensory evoked potential monitoring during spinal surgery in adolescents. Pediatr Anesth 2008;18:1082-8
61. Ard J, Doyle W, Bekker A. Awake craniotomy with dexmedetomidine in pediatric patients. J Neurosurg Anesthesiol 2003;15:263-6 (Pubitemid 36807890)
62. Everett LL, van Rooyen IF, Warner MH, et al. Use of dexmedetomidine in awake craniotomy in adolescents: report of two cases. Pediatr Anesth 2006;16:338-42
63. Sadhasivam S, Boat A, Mahmoud M. Comparison of patient-controlled analgesia with and without dexmedetomidine following spine surgery in children. J Clin Anesth 2009;21:493-501
64. Easley RB, Brady KM, Tobias JD. Dexmedetomidine for the treatment of postanesthesia shivering in children. Pediatr Anesth 2007;17:341-6
65. Chrysostomou C, Beerman L, Shiderly D, et al. Dexmedetomidine: a novel drug for the treatment of atrial and junctional tachyarrhythmias during the perioperative period for congenital cardiac surgery: a preliminary study. Anesth Analg 2008;107:1514-22
66. Baddigam K, Russo P, Russo J, Tobias JD. Dexmedetomidine in the treatment of withdrawal syndromes in cardiothoracic surgery patients. J Intensive Care Med 2005;20:118-23 (Pubitemid 43093903)
67. Finkel JC, Elrefai A. The use of dexmedetomidine to facilitate opioid and benzodiazepine detoxification in an infant. Anesth Analg 2004;98:1658-9 (Pubitemid 38668910)
68. Finkel JC, Johnson YJ, Quezado ZMN. The use of dexmedetomidine to facilitate acute discontinuation of opioids after cardiac transplantation in children. Crit Care Med 2005;33:2110-12
69. Tobias JD, Berkenbosch JW, Russo P. Additional experience with dexmedetomidine in pediatric patients. South Med J 2003;96:871-5 (Pubitemid 38279587)
70. Tobias JD. Dexmedetomidine to treat opioid withdrawal in infants following prolonged sedation in the pediatric ICU. J Opioid Manag 2006;2:201-5
71. Precedex-(dexmedetomidine HCL injection) Product Label. Hospira, Inc. Lake Forest, IL 2008. Available from: www.precedex.com/safety/full-prescribing- information/[Last accessed 26 July 2010]
72. Bloor BC, Ward DS, Belleville JP, Maze M. Effects of intravenous dexmedetomidine in humans: II. Hemodynamic changes. Anesthesiology 1992;77:1134-42
73. Venn RM, Bradshaw CJ, Spencer R, et al. Preliminary UK experience of dexmedetomidine a novel agent for postoperative sedation in the intensive care unit. Anaesthesia 1999;54:1136-42
74. Mester R, Easley RB, Brady KM, et al. Monitored anesthesia care with a combination of ketamine and dexmedetomidine during cardiac catheterization. Am J Ther 2008;15:24-30 (Pubitemid 351161178)
75. Potts AL, Anderson BJ, Holford NHG, et al. Dexmedetomidine hemodynamics in children after cardiac surgery. Pediatr Anesth 2010;20:425-33
76. Hammer GB, Drover DR, Cao H, et al. The effects of dexmedetomidine on cardiac electrophysiology in children. Anesth Analg 2008;106:79-83
77. Chrysostomou C, Komarlu R, Lichtenstein S, et al. Electrocardiographic effects of dexmedetomidine in patients with congenital heart disease. Intensive Care Med 2010;36:836-42
78. Tokuhira N, Atagi K, Shimaoka H, et al. Dexmedetomidine sedation for pediatric post-Fontan procedure patients. Pediatr Crit Care Med 2009;10:207-12
79. Okabe T, Takeda S, Akada S, et al. Postoperative intensive care unit drug fever caused by dexmedetomidine. Anesth Analg 2009;108:1589-91
80. Rosen DA, Daume JT. Short duration large dose dexmedetomidine in a pediatric patient during procedural sedation. Anesth Analg 2006;103:68-9
81. Bernard PA, Makin CE, Werner HA. Hypoglycemia associated with dexmedetomidine overdose in a child? J Clin Anesth 2009;21:50-3
82. Lazol JP, Lichtenstein SE, Jooste EH, et al. Effect of dexmedetomidine on pulmonary artery pressure after congenital cardiac surgery: a pilot study. Pediatr Crit Care Med 2010;11:1-4
83. OMara K, Gal P, Ransommd JL, et al. Successful use of dexmedetomidine for sedation in a 24-week gestational age neonate. Ann Pharmacother 2009;43:1707-13